GlaxoSmithKline’s (LON: GSK) share price gained 1% after reporting better-than-expect first-quarter results on Wednesday.
The healthcare company posted strong sales of £9.8 billion, beating forecasts and gaining 32% year on year. Meanwhile, earnings per share reached 32.8p and beat average analyst estimates of 30p per share. The company said it experienced strong sales growth across its biopharma and consumer healthcare divisions, seeing robust demand for its Covid-19 antibody treatment and a recovery in its shingles vaccine demand.
“We have delivered strong first quarter results in this landmark year for GSK, as we separate Consumer Healthcare and start a new period of sustained growth,” stated Emma Walmsley, Chief Executive Officer of GSK.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“Our results reflect further good momentum across specialty medicines and vaccines, including the return to strong sales growth for Shingrix and continuing pipeline progress,” added Walmsley.
GSK also declared a dividend of 14p for the first quarter.
Furthermore, GSK reiterated its 2022 guidance. The company expects to deliver sales growth of between 5% to 7% and operating profit growth of between 12% to 14%.
Guidance excludes any contribution from Covid-19 solutions such as Xevudy, used as an antibody treatment to treat patients infected with Omicron.
